Artesunate/mefloquine
| Combination of | |
|---|---|
| Artesunate | artemisinin |
| Mefloquine | antimalarial |
| Clinical data | |
| ATC code | |
| Identifiers | |
| CAS Number | |
| CompTox Dashboard (EPA) | |
Artesunate/mefloquine is a medication used to treat
Side effects are similar to the medications being used separately.[2] Use is recommended as it decreases the possibility of either medications being used alone.[2] Dose forms appropriate for children are also available.[2]
Artesunate/mefloquine came into commercial use in 2008.[3] It is on the World Health Organization's List of Essential Medicines.[1] It is approved for medical use in Brazil, India, and Malaysia.[2] It is not commercially available in the United States.[4]
Medical uses
Artesunate/mefloquine is a recommended treatment in Southeast Asia while in Africa artesunate/amodiaquine, artemether/lumefantrine, artesunate/sulfadoxine/pyrimethamine are often preferred.[5]
See also
- Dihydroartemisinin/piperaquine
References
- ^ hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ ISBN 9789241209854.
- ISBN 9783034604802. Archivedfrom the original on 2016-12-20.
- ISBN 9780323417426. Archivedfrom the original on 2016-12-20.
- ISBN 9783319138848. Archivedfrom the original on 2016-12-20.
External links
- "Artesunate mixture with mefloquine". Drug Information Portal. U.S. National Library of Medicine.
